Skip to main content
. 2022 Jan 29;41(9):1376–1382. doi: 10.1038/s41388-021-02161-1

Fig. 5. BOK is not subjected to copy number variation in lung cancer patients.

Fig. 5

a, b Copy number aberrations (CNA) expressed as frequency in TRACERx LUAD (a, n = 61) and LUSC (b, n = 32) tumors. c, d CNA expressed as frequency in TRACERx LUAD grouped for TP53 wildtype (WT) in LUAD (c, n = 33) and LUSC (d, n = 3). Shading indicates clonal status. Dashed purple lines represent threshold for frequent gains and losses.